STL Index for: Nuha Nasir
A Novel Fixed Dose Triple Combination Therapy (IDP-126) for Moderate to Severe Acne
IDP-126 is a novel fixed-dose topical gel combining clindamycin, benzoyl peroxide, and adapalene for moderate to severe acne. Approved by the FDA and Health Canada, it showed superior efficacy over dual therapies in phase 2 and 3 trials, with strong safety and tolerability outcomes.
